Literature DB >> 28762163

Polycystin 2-dependent cardio-protective mechanisms revealed by cardiac stress.

Esther Giehl1,2, Fernanda O Lemos2, Yan Huang3, Frank J Giordano3, Ivana Y Kuo2, Barbara E Ehrlich4,5.   

Abstract

Although autosomal dominant polycystic kidney disease (ADPKD) is characterized by the development of multiple kidney cysts, the most frequent cause of death in ADPKD patients is cardiovascular disease. ADPKD is linked to mutations in PKD1 or pkd2, the genes that encode for the proteins polycystin 1 and polycystin 2 (PC1 and PC2, respectively). The cardiovascular complications have been assumed to be a consequence of renal hypertension and activation of renin/angiotensin/aldosterone (RAAS) pathway. However, the expression of PC1 and PC2 in cardiac tissue suggests additional direct effects of these proteins on cardiac function. We previously reported that zebrafish lacking PC2 develop heart failure, and that heterozygous Pkd2+/- mice are hypersensitive to acute β-adrenergic receptor (βAR) stimulation. Here, we investigate the effect of cardiac stress (prolonged continuous βAR stimulus) on Pkd2+/- mice. After βAR stimulation for 7 days, wild-type (WT) mice had increased left ventricular mass and natriuretic peptide (ANP and BNP) mRNA levels. The WT mice also had upregulated levels of PC2 and chromogranin B (CGB, an upstream regulator of BNP). Conversely, Pkd2+/- mice had increased left ventricular mass, but natriuretic peptide and CGB expression levels remained constant. Reversal of the increased cardiac mass was observed in WT mice 3 days after cessation of the βAR stimulation, but not in Pkd2+/- mice. We suggest that cardiac stress leads to upregulation of the PC2-CGB-BNP signaling axis, and this pathway regulates the production of cardio-protective natriuretic peptides. The lack of a PC2-dependent cardio-protective function may contribute to the severity of cardiac dysfunction in Pkd2+/- mice and in ADPKD patients.

Entities:  

Keywords:  ADPKD; Adrenergic response; Calcium signaling; Cardiac stress; Natriuretic peptide; Polycystin

Mesh:

Substances:

Year:  2017        PMID: 28762163      PMCID: PMC5792378          DOI: 10.1007/s00424-017-2042-7

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  53 in total

1.  Left ventricular hypertrophy in autosomal dominant polycystic kidney disease.

Authors:  A B Chapman; A M Johnson; S Rainguet; K Hossack; P Gabow; R W Schrier
Journal:  J Am Soc Nephrol       Date:  1997-08       Impact factor: 10.121

Review 2.  Autosomal dominant polycystic kidney disease.

Authors:  Vicente E Torres; Peter C Harris; Yves Pirson
Journal:  Lancet       Date:  2007-04-14       Impact factor: 79.321

Review 3.  Thirty years of the heart as an endocrine organ: physiological role and clinical utility of cardiac natriuretic hormones.

Authors:  Aldo Clerico; Alberto Giannoni; Simona Vittorini; Claudio Passino
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-05-06       Impact factor: 4.733

4.  Natural history and expansive clinical profile of stress (tako-tsubo) cardiomyopathy.

Authors:  Scott W Sharkey; Denise C Windenburg; John R Lesser; Martin S Maron; Robert G Hauser; Jennifer N Lesser; Tammy S Haas; James S Hodges; Barry J Maron
Journal:  J Am Coll Cardiol       Date:  2010-01-26       Impact factor: 24.094

5.  Polycystin-1 Is a Cardiomyocyte Mechanosensor That Governs L-Type Ca2+ Channel Protein Stability.

Authors:  Zully Pedrozo; Alfredo Criollo; Pavan K Battiprolu; Cyndi R Morales; Ariel Contreras-Ferrat; Carolina Fernández; Nan Jiang; Xiang Luo; Michael J Caplan; Stefan Somlo; Beverly A Rothermel; Thomas G Gillette; Sergio Lavandero; Joseph A Hill
Journal:  Circulation       Date:  2015-04-17       Impact factor: 29.690

6.  Polycystin-2 mutations lead to impaired calcium cycling in the heart and predispose to dilated cardiomyopathy.

Authors:  Jere Paavola; Simon Schliffke; Sandro Rossetti; Ivana Y-T Kuo; Shiaulou Yuan; Zhaoxia Sun; Peter C Harris; Vicente E Torres; Barbara E Ehrlich
Journal:  J Mol Cell Cardiol       Date:  2013-01-30       Impact factor: 5.000

7.  Left ventricular mass and diastolic function in normotensive young adults with autosomal dominant polycystic kidney disease.

Authors:  A Bardají; A M Vea; C Gutierrez; C Ridao; C Richart; J A Oliver
Journal:  Am J Kidney Dis       Date:  1998-12       Impact factor: 8.860

Review 8.  What is the role of beta-adrenergic signaling in heart failure?

Authors:  Martin J Lohse; Stefan Engelhardt; Thomas Eschenhagen
Journal:  Circ Res       Date:  2003-11-14       Impact factor: 17.367

9.  Predicted Mutation Strength of Nontruncating PKD1 Mutations Aids Genotype-Phenotype Correlations in Autosomal Dominant Polycystic Kidney Disease.

Authors:  Christina M Heyer; Jamie L Sundsbak; Kaleab Z Abebe; Arlene B Chapman; Vicente E Torres; Jared J Grantham; Kyongtae T Bae; Robert W Schrier; Ronald D Perrone; William E Braun; Theodore I Steinman; Michal Mrug; Alan S L Yu; Godela Brosnahan; Katharina Hopp; Maria V Irazabal; William M Bennett; Michael F Flessner; Charity G Moore; Douglas Landsittel; Peter C Harris
Journal:  J Am Soc Nephrol       Date:  2016-01-28       Impact factor: 10.121

10.  Decreased Polycystin 2 Levels Result in Non-Renal Cardiac Dysfunction with Aging.

Authors:  Ivana Y Kuo; Sophie L Duong; Lily Nguyen; Barbara E Ehrlich
Journal:  PLoS One       Date:  2016-04-15       Impact factor: 3.240

View more
  6 in total

1.  Polycystin 2: A calcium channel, channel partner, and regulator of calcium homeostasis in ADPKD.

Authors:  Allison L Brill; Barbara E Ehrlich
Journal:  Cell Signal       Date:  2019-12-02       Impact factor: 4.315

2.  Proteomic Analysis of Effects of Spironolactone in Heart Failure With Preserved Ejection Fraction.

Authors:  Ali Javaheri; Ahmed Diab; Lei Zhao; Chenao Qian; Jordana B Cohen; Payman Zamani; Anupam Kumar; Zhaoqing Wang; Christina Ebert; Joseph Maranville; Erika Kvikstad; Michael Basso; Vanessa van Empel; A Mark Richards; Robert N Doughty; Ernst Rietzschel; Karl Kammerhoff; Joseph Gogain; Peter Schafer; Dietmar A Seiffert; David A Gordon; Francisco Ramirez-Valle; Douglas L Mann; Thomas P Cappola; Julio A Chirinos
Journal:  Circ Heart Fail       Date:  2022-08-09       Impact factor: 10.447

3.  Oxidative stress in autosomal dominant polycystic kidney disease: player and/or early predictor for disease progression?

Authors:  Asmin Andries; Kristien Daenen; François Jouret; Bert Bammens; Djalila Mekahli; Ann Van Schepdael
Journal:  Pediatr Nephrol       Date:  2018-08-13       Impact factor: 3.714

Review 4.  Role of PKD2 in the endoplasmic reticulum calcium homeostasis.

Authors:  Xiong Liu; Jingfeng Tang; Xing-Zhen Chen
Journal:  Front Physiol       Date:  2022-08-10       Impact factor: 4.755

5.  Smoking accelerates renal cystic disease and worsens cardiac phenotype in Pkd1-deficient mice.

Authors:  Marciana V Sousa; Andressa G Amaral; Jessica A Freitas; Gilson M Murata; Elieser H Watanabe; Bruno E Balbo; Marcelo D Tavares; Renato A Hortegal; Camila Rocon; Leandro E Souza; Maria C Irigoyen; Vera M Salemi; Luiz F Onuchic
Journal:  Sci Rep       Date:  2021-07-14       Impact factor: 4.379

6.  Polycystin 2 is increased in disease to protect against stress-induced cell death.

Authors:  Allison L Brill; Tom T Fischer; Jennifer M Walters; Arnaud Marlier; Lorenzo R Sewanan; Parker C Wilson; Eric K Johnson; Gilbert Moeckel; Lloyd G Cantley; Stuart G Campbell; Jeanne M Nerbonne; Hee Jung Chung; Marie E Robert; Barbara E Ehrlich
Journal:  Sci Rep       Date:  2020-01-15       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.